Nunzia Pharmaceutical Stock Analysis

NUNZ Stock  USD 0  0.00  0.00%   
Nunzia Pharmaceutical is overvalued with Real Value of 0.00252 and Hype Value of 0.003. The main objective of Nunzia Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Nunzia Pharmaceutical is worth, separate from its market price. There are two main types of Nunzia Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Nunzia Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nunzia Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Nunzia Pink Sheet Analysis Notes

About 82.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.28. Nunzia Pharmaceutical last dividend was issued on the 4th of December 2019. The entity had 1:7000 split on the 4th of December 2019. Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.The quote for Nunzia Pharmaceutical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Nunzia Pharmaceutical contact Sara Gonzales at 714 609 9117 or learn more at https://www.nunziapharma.com.

Nunzia Pharmaceutical Investment Alerts

Nunzia Pharmaceutical generated a negative expected return over the last 90 days
Nunzia Pharmaceutical has some characteristics of a very speculative penny stock
Nunzia Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
Nunzia Pharmaceutical currently holds 139.96 K in liabilities. Nunzia Pharmaceutical has a current ratio of 0.2, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nunzia Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Nunzia Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nunzia Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nunzia to invest in growth at high rates of return. When we think about Nunzia Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (9.02 M) with profit before overhead, payroll, taxes, and interest of 0.
Nunzia Pharmaceutical currently holds about 5.07 K in cash with (86.78 K) of positive cash flow from operations.
Roughly 82.0% of the company outstanding shares are owned by corporate insiders

Nunzia Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.88 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nunzia Pharmaceutical's market, we take the total number of its shares issued and multiply it by Nunzia Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nunzia Pharmaceutical, as well as the relationship between them.

Nunzia Pharmaceutical Price Movement Analysis

Execute Study
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nunzia Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nunzia Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

About Nunzia Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Nunzia Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nunzia shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Nunzia Pharmaceutical. By using and applying Nunzia Pink Sheet analysis, traders can create a robust methodology for identifying Nunzia entry and exit points for their positions.
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Nunzia Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Additional Tools for Nunzia Pink Sheet Analysis

When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.